Menu

Lasker Awards Recognize Work on Histones, Anesthesia, RNA

This year’s winners are C. David Allis, Michael Grunstein, John Glen, and Joan Steitz.

Sep 11, 2018
Shawna Williams
From left to right: C. David Allis, Michael Grunstein, John Glen, and Joan Steitz
ALBERT AND MARY LASKER FOUNDATION

The winners of this year’s Lasker Awards are C. David Allis of Rockefeller University and Michael Grunstein of the University of California, Los Angeles, for discoveries about the proteins that package DNA; John “Iain” Glen, formerly a pharmaceutical researcher at AstraZeneca, for developing the drug propofol; and Yale University’s Joan Steitz for leadership and research throughout her career, the Lasker Foundation announced today (September 11). The Laskers, prestigious awards often used to forecast future Nobel Prize winners, each come with a cash prize of $250,000.

At one time, Grunstein recalled in a teleconference with the media today, most researchers assumed that because the histone proteins that package DNA are highly conserved among vastly different species, they must not be very interesting. But in the 1980s, “we found that they’re very important, not only as packing material, but as proteins that regulate gene activity,” he says. 

Allis and colleagues would later uncover more details about how this regulation works, including an enzyme that removes acetyl tags on histones, changing genes’ expression levels. The work helped lay the foundation for developing drugs for cancer and other conditions that involve aberrant histone tags.

See “Support for Histone Code?

In an interview with Science, Glen, a former veterinarian, recalls how it took 13 years to develop propofol, now one of the world’s most-used anesthetics. “I remember knowing it was special when I saw how quickly the animals recovered after they woke up,” he tells the magazine. “A whole pen of pigs could be out cold one moment, and then digging into their food the next.”

Steitz’s award recognizes not a specific achievement, but her “four decades of leadership in biomedical science,” according to the Lasker’s statement. She is known for her discovery that small nuclear ribonucleoproteins (snRNPs) are key players in splicing finished mRNA transcripts within cells, and for other RNA-related work. 

She has also been an advocate for women in science. “When I started out being excited by science—but seeing that there weren’t any women scientists—I thought I had no prospects whatsoever,” she tells The New York Times. Her aim, she says, is to be “a good citizen and try to help women and other underrepresented people to fulfill their potential.”

April 2019

Will Car T Cells Smash Tumors?

New trials take the therapy beyond the blood

Marketplace

Sponsored Product Updates

Getting More Consistent Results by Knowing the Quality of Your Protein
Getting More Consistent Results by Knowing the Quality of Your Protein
Download this guide from NanoTemper to learn how to identify and evaluate the quality of your protein samples!
Myth Busting: The Best Way to Use Pure Water in the Lab
Myth Busting: The Best Way to Use Pure Water in the Lab
Download this white paper from ELGA LabWater to learn about the role of pure water in the laboratory and the advantages of in-house water purification!
Shimadzu's New Nexera UHPLC Series with AI and IoT Enhancements Sets Industry Standard for Intelligence, Efficiency and Design
Shimadzu's New Nexera UHPLC Series with AI and IoT Enhancements Sets Industry Standard for Intelligence, Efficiency and Design
Shimadzu Corporation announces the release of the Nexera Ultra High-Performance Liquid Chromatograph series, incorporating artificial intelligence as Analytical Intelligence, allowing systems to detect and resolve issues automatically. The Nexera series makes lab management simple by integrating IoT and device networking, enabling users to easily review instrument status, optimize resource allocation, and achieve higher throughput.
IDT lowers genomic barriers with powerful rhAmpSeq™ targeted sequencing system
IDT lowers genomic barriers with powerful rhAmpSeq™ targeted sequencing system
Increasing accuracy and reducing cost barriers, IDT’s innovative system delivers simple and cost-effective amplicon sequencing